179 related articles for article (PubMed ID: 38096797)
1. Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review.
Pietrzak-Nowacka M; Safranow K; Płońska-Gościniak E; Nowacki A; Późniak P; Gutowski P; Ciechanowski K
Kidney Blood Press Res; 2024; 49(1):9-19. PubMed ID: 38096797
[TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.
Alzahrani OR; Alatwi HE; Alharbi AA; Alessa AH; Al-Amer OM; Alanazi AFR; Shams AM; Alomari E; Naser AY; Alzahrani FA; Hosawi S; Alghamdi SM; Abdali WA; Elfaki I; Hawsawi YM
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422197
[TBL] [Abstract][Full Text] [Related]
3. TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.
Magistroni R; Mangolini A; Guzzo S; Testa F; Rapanà MR; Mignani R; Russo G; di Virgilio F; Aguiari G
BMC Nephrol; 2019 Sep; 20(1):355. PubMed ID: 31514750
[TBL] [Abstract][Full Text] [Related]
4. Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy.
Paavola J; Schliffke S; Rossetti S; Kuo IY; Yuan S; Sun Z; Harris PC; Torres VE; Ehrlich BE
J Mol Cell Cardiol; 2013 May; 58():199-208. PubMed ID: 23376035
[TBL] [Abstract][Full Text] [Related]
5. Identification of Biomarkers for PKD1 Using Urinary Exosomes.
Hogan MC; Bakeberg JL; Gainullin VG; Irazabal MV; Harmon AJ; Lieske JC; Charlesworth MC; Johnson KL; Madden BJ; Zenka RM; McCormick DJ; Sundsbak JL; Heyer CM; Torres VE; Harris PC; Ward CJ
J Am Soc Nephrol; 2015 Jul; 26(7):1661-70. PubMed ID: 25475747
[TBL] [Abstract][Full Text] [Related]
6. PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease.
Shigemori K; Higashihara E; Itoh M; Yoshida H; Yamamoto K; Nutahara K; Shiokawa Y; Kaname S; Tambo M; Yamaguchi T; Taguchi S; Yoshioka T; Yokoyama K; Fukuhara H
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105943. PubMed ID: 34175641
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.
Aguiari G; Banzi M; Gessi S; Cai Y; Zeggio E; Manzati E; Piva R; Lambertini E; Ferrari L; Peters DJ; Lanza F; Harris PC; Borea PA; Somlo S; Del Senno L
FASEB J; 2004 May; 18(7):884-6. PubMed ID: 15001556
[TBL] [Abstract][Full Text] [Related]
8. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling.
Xu C; Rossetti S; Jiang L; Harris PC; Brown-Glaberman U; Wandinger-Ness A; Bacallao R; Alper SL
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F930-45. PubMed ID: 17090781
[TBL] [Abstract][Full Text] [Related]
9. The Pathophysiology of Left Ventricular Hypertrophy, beyond Hypertension, in Autosomal Dominant Polycystic Kidney Disease.
Oto OA; Edelstein CL
Nephron; 2024; 148(4):215-223. PubMed ID: 35896062
[TBL] [Abstract][Full Text] [Related]
10. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
11. Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.
Jung HJ; Dixon EE; Coleman R; Watnick T; Reiter JF; Outeda P; Cebotaru V; Woodward OM; Welling PA
Physiol Genomics; 2023 Nov; 55(11):565-577. PubMed ID: 37720991
[TBL] [Abstract][Full Text] [Related]
12. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
[TBL] [Abstract][Full Text] [Related]
13. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
[TBL] [Abstract][Full Text] [Related]
14. Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.
Karava V; Benzouid C; Hogan J; Dossier C; Denjean AP; Deschênes G
Pediatr Nephrol; 2018 Sep; 33(9):1513-1521. PubMed ID: 29774463
[TBL] [Abstract][Full Text] [Related]
15. Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress.
Giehl E; Lemos FO; Huang Y; Giordano FJ; Kuo IY; Ehrlich BE
Pflugers Arch; 2017 Nov; 469(11):1507-1517. PubMed ID: 28762163
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.
Ecder T; Schrier RW
Nat Rev Nephrol; 2009 Apr; 5(4):221-8. PubMed ID: 19322187
[TBL] [Abstract][Full Text] [Related]
17. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
Krappitz M; Bhardwaj R; Dong K; Staudner T; Yilmaz DE; Pioppini C; Westergerling P; Ruemmele D; Hollmann T; Nguyen TA; Cai Y; Gallagher AR; Somlo S; Fedeles S
J Am Soc Nephrol; 2023 Jan; 34(1):110-121. PubMed ID: 36270750
[TBL] [Abstract][Full Text] [Related]
18. Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.
Brill AL; Ehrlich BE
Cell Signal; 2020 Feb; 66():109490. PubMed ID: 31805375
[TBL] [Abstract][Full Text] [Related]
19. Cilia and polycystic kidney disease.
Ma M
Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
